https://www.indianpharmapost.com/takeda-seals-12-billion-oncology-deal-with-innovent-biologics-184752025-12-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayer-advances-fight-against-rare-kidney-disease-with-new-experimental-drug-184762025-12-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/denali-clinches-275-million-royalty-deal-to-power-potential-breakthrough-hunter-syndrome-therapy-184772025-12-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/paradigm-health-to-acquire-flatirons-clinical-research-business-184782025-12-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayer-launches-phase-iii-trial-testing-mirena-for-uterine-condition-with-no-treatments-184792025-12-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/debiopharm-launches-pivotal-phase-iii-trial-for-novel-quarterly-acromegaly-treatment-184802025-12-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayer-reports-promising-results-for-low-dose-pediatric-mri-contrast-agent-184812025-12-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-to-merge-biocon-biologics-in-55-billion-deal-184822025-12-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/clariant-showcases-vitipure-portfolio-at-cphi-india-184832025-12-07T00:00:00+05:30always0.9